脑部放疗，上午比下午敏感许多！: f+ G; l& U1 J1 n+ d
2 l2 X7 Y% s: s! P7 a& Z( n
. e; t8 a V8 L4 }* |
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
5 C+ r: N- A0 _Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?9 B, \: o' N% D. _$ l8 u. ?! i- C2 l
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
8 o9 |8 p; a1 J1 L) ~7 x" |8 v- HSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.! c6 q3 z" m7 Z6 Q
: ]- a+ O! m+ l( o" p6 v1 o- lAbstract9 y6 G9 G( Q6 G7 b
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
1 {( S4 p$ o( W ^5 c0 M8 B9 n6 i: c4 u* g) f+ `% D6 c( K8 Y
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic." p! O6 k8 Z7 p0 e1 |
) ~* ], R2 \; ~3 J: R& [RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026). q+ Z9 f& x* i A Z
( S/ e0 O6 \2 H9 eCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
& Z6 P) _! ^6 o2 h/ N5 M$ z& w4 e0 G
# ~) A ]: ~ e* I. Z |
% I5 {7 A7 J3 D% x; Y3 r
显身卡
